DAVE;
DAVE;
DAVE;
DAVE;
DAVE;
DAVE;
DAVE;
DAVE;
DAVE;
DAVE;
DAVE;

About DAVE™

The Pharmaceutical Alliance is helping to address some of the significant challenges faced by GPs in the area of type 2 diabetes with the development of DAVE™, a unique state-of-the-art EDSS (Electronic Decision Support System). 

Developed in partnership with GPs, diabetes experts and Diabetes Australia, DAVE™ helps healthcare professionals successfully complete the complex reviews and decision-making processes for type 2 diabetes patients within the time constraints of a consult.

Based on the latest clinical guidelines, it ultimately promotes the provision of effective, evidence-based diabetes management plans.

Why is the software called DAVE™?

Feedback from our users has been that it's like having a 'third person' in the patient consultation - one that helps the consultation be thorough, interactive yet efficient.

How it works

The software design is based on findings from research commissioned by The Alliance, which highlight the very real difficulties medical practitioners face every day in managing type 2 diabetes – specifically the challenges in being able to succinctly view the details relevant to a patient’s diabetes status.

Achieving targets in diabetes care click here

DAVE™ allows GPs, for the first time, to clearly review the relevant clinical data for their type 2 diabetes patients as well as assess their overall health status and relevant health issues. Based on the latest clinical guidelines, it promotes the provision of effective evidence-based diabetes management plans and allows the practitioner to facilitate a thorough, interactive, yet efficient consultation based on latest clinical evidence.

The DAVE™ software links effectively with existing clinical record systems enabling the data to be read from, and recorded back into, the core GP system. The tool brings all the critical information together in an easy-to-review format to help GPs and practice nurses proactively monitor their patient’s health status and progress to clinical treatment goals.

The software can be applied to any type of diabetes management, although it specifically allows a more meaningful dialogue with patients who have type 2 diabetes due to the numerous modifiable risks involved.

Key features

  • A diabetes ‘toolbar’ showing the patient’s latest key measurements, highlighting whether these are at the recommended level or due for a check-up
  • Brings all critical information together in an easy-to-review format to cover all aspects of the patient’s condition
  • Allows GPs to proactively monitor the patient’s health status and progress to clinical treatment goals
  • Links with existing clinical record systems enabling the data to be read from and recorded back into the core GP system

Additional features

  • Prompts informed discussion through interactive and informative summary screens
  • Easy-to-use analytical screens and graphs to highlight the patient’s progress
  • Linked to NHMRC and DA / RACGP diabetes management guidelines
  • Provides a workflow oriented approach to data entry
  • Chronological and cumulative summary
  • Task reminders
  • Access to resources for GPs and patients
  • Direct links to useful patient information and support tools

The ultimate outcome

The work of The Pharmaceutical Alliance is focused on maximising every interaction GPs have with their type 2 diabetes patients to achieve greater control of this complex chronic disease and reduce associated health complications, and ultimately maintain or improve the patient’s quality of life.

Research shows Electronic Decision Support Systems contribute to improved quality and safety of healthcare and better patient outcomes. The software tool will be one of the first healthcare software systems for management of a chronic disease to be independently evaluated, on both a qualitative and quantitative level. 1

Measuring outcomes click here

References
  1. AIHW General practice activity in Australia 2007-08 (BEACH program – 10th year)
DAVE

 

“The Alliance has been proactive and enthusiastic in seeking grassroots GP input in the creation of this comprehensive evidence-based management support tool, which promotes best practice treatment to target and quality use of medicines.”
Dr Wes Jame, a GP from Berwick in Victoria

  

 

 

“The new tool provides a timely reminder to GPs that their patient has diabetes, any outstanding items which require attention and provides guidance on how these should be managed.”
Professor Stephen Colagiuri, Professor of Metabolic Health at the University of Sydney

  

 

 

“I’m really enthusiastic about the use of this tool in general practice; it means that all GPs in our practice are now dancing to the same tune – asking the same questions and adhering to the same standards.”
Dr Wes Jame, a GP from Berwick in Victoria

  

 

 

“It gives you more evidence which is important when trying to influence patient behaviour and promote lifestyle modification.”
Dr Charlotte Hespe, a GP from Glebe in Sydney

  

 

 

“Innovative use of technology improves healthcare when the GP can easily access tools to guide patient management. The diabetes software tool is unique in putting together the elements of an effective desktop management system and is long overdue! The patient’s results are matched to evidence-based goals and the GP has a visual update of all the elements needing review.”
Dr Gary Deed, a GP from Brisbane and past President of Diabetes Australia

 

 

 

“The potential for this type of tool to reform the way diabetes is managed is considerable as it’s relatively easy during a short consultation for both the patient and doctor to overlook essential aspects of diabetes care.”
Professor Stephen Colagiuri, Professor of Metabolic Health at the University of Sydney

  

 

 

"Decision tools break down the knowledge, and the decisions needed at a given part of an algorithm path, into small steps. The likelihood of following guidelines is greater when we can get our heads around them, regularly and rigorously, in a systematic way, without having to remember everything ourselves."
Dr Linda Mann, a GP from Leichhardt in Sydney, Medical Educator at the Sydney Institute for GP Education & Training and RACGP Representative on Editorial Panel

  

Privacy   |   Terms of use  |   Intellectual Property   |   powered by SiteSuite
The Pharmaceutical Alliance

The Pharmaceutical Alliance seeks views and guidance from a broad range of healthcare professionals. Where appropriate for these consultations, the Alliance provides remuneration specifically to cover their  time away from day-to-day responsibilities.  The Pharmaceutical Alliance has not provided any payment for comments expressed by people regarding the Alliance or its work. All views represent the opinions of the individual author and are independent of The Pharmaceutical Alliance.